Program

99
92
5
3
2
1
1

Journal Year Published

11
16
11
20
10
8
9
10
12
12
10
12
4

Author

145
185
178
136
125
123
118
117
108
99
88
81
77
58
54
50
46
46
42
37

Category

75
47
31
25
6
5
2
2
2
1
1

Keyword

58
43
32
19
18
16
15
15
14
13
13
12
12
12
11
11
10
10
10
9

Journal

16
13
12
5
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2

NCATS Publications

Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts.


Onda M, Ghoreschi K, Steward-Tharp S, Thomas C, O'Shea JJ, Pastan IH, FitzGerald DJ


J. Immunol. , (193), 48-55, 2014.

Article Pubmed

Sample image from publication page

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.


Mathews Griner LA, Guha R, Shinn P, Young RM, Keller JM, Liu D, Goldlust IS, Yasgar A, McKnight C, Boxer MB, Duveau D, Jiang J, Michael S, Mierzwa T, Huang W, Walsh MJ, Mott BT, Patel P, Leister W, Maloney DJ, LeClair C, Rai Bantukallu G, Jadhav A, Peyser BD, Austin C, Martin SE, Simeonov A, Ferrer-Alegre M, Staudt LM, Thomas C


Proc. Natl. Acad. Sci. U.S.A. , (111), 2349-54, 2014.

Article Pubmed

Sample image from publication page

A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor.


Jiang J, McCoy JG, Shen M, LeClair C, Huang W, Negri A, Li J, Blue R, Harrington AW, Naini S, David G, Choi WS, Volpi E, Fernandez J, Babayeva M, Nedelman MA, Filizola M, Coller BS, Thomas C


Bioorg. Med. Chem. Lett. , (24), 1148-53, 2014.

Article Pubmed

Sample image from publication page

CD28 and ITK signals regulate autoreactive T cell trafficking.


Jain N, Miu B, Jiang J, McKinstry KK, Prince A, Swain SL, Greiner DL, Thomas C, Sanderson MJ, Berg LJ, Kang J


Nat. Med. , (19), 1632-7, 2013.

Article Pubmed

Sample image from publication page

Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.


Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas C, Discepolo V, Jabri B, Waldmann TA


Proc. Natl. Acad. Sci. U.S.A. , (110), 13534-9, 2013.

Article Pubmed

Sample image from publication page

Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.


Rhyasen GW, Bolanos L, Fang J, Jerez A, Wunderlich M, Rigolino C, Mathews L, Ferrer-Alegre M, Southall N, Guha R, Keller J, Thomas C, Beverly LJ, Cortelezzi A, Oliva EN, Cuzzola M, Maciejewski JP, Mulloy JC, Starczynowski DT


Cancer Cell , (24), 90-104, 2013.

Article Pubmed

Sample image from publication page

Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma.


McDonnell SR, Hwang SR, Rolland D, Murga-Zamalloa C, Basrur V, Conlon KP, Fermin D, Wolfe T, Raskind A, Ruan C, Jiang J, Thomas C, Hogaboam CM, Burant CF, Elenitoba-Johnson KS, Lim MS


Blood , (122), 958-68, 2013.

Article Pubmed

Sample image from publication page